CEA [CHINA EASTERN AIRLINES] 6-K: (Original Filing)
[]
LITB [LightInTheBox] 6-K: (Original Filing)
[LightInTheBox Holding Co., Ltd. Responds to Class Action Lawsuit The Company has reviewed the claims asserted in the complaint and believes that they are without merit. While the Company has not yet been served with a copy of the complaint, it intends to work with Simpson Thacher & Bartlett LLP, its legal counsel, to vigorously defend itself in this matter.]
LITB [LightInTheBox] 6-K: LightInTheBox Holding Co., Ltd. Responds to Class Action
[LightInTheBox Holding Co., Ltd. Responds to Class Action Lawsuit The Company has reviewed the claims asserted in the complaint and believes that they are without merit. While the Company has not yet been served with a copy of the complaint, it intends to work with Simpson Thacher & Bartlett LLP, its legal counsel, to vigorously defend itself in this matter.]
BSPM [Biostar Pharmaceuticals,] S-8: (Original Filing)
[FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer No. 588 Shiji Xi Avenue,] [Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: Schiff Hardin LLP EX-5.1 3 ex5-1.htm] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated August 28, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong August 28, 2013 EX-23.2 5 ex23-2.htm]
BSPM [Biostar Pharmaceuticals,] S-8: FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT
[FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer No. 588 Shiji Xi Avenue,] [Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: Schiff Hardin LLP EX-5.1 3 ex5-1.htm] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated August 28, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong August 28, 2013 EX-23.2 5 ex23-2.htm]
JASO [JA Solar] 6-K: (Original Filing)
[JA Solar to Develop 300 MW of Solar Power Projects in Xingtai City, Hebei Province SHANGHAI, China, August 27, 2013 JA Solar Holdings Co., Ltd. (Nasdaq:JASO) (JA Solar or the Company), one of the worlds largest manufacturers of high-performance solar power products, today announced that it plans to develop three solar power projects totaling 300 MW in Xingtai City]
FFHL [Fuwei Films] 6-K: Fuwei Films Learns Result of Auction of Controlling
[Fuwei Films Learns Result of Auction of Controlling Interest BEIJING, August 27, 2013 The auction was held on August 27, 2013 at 10 am in Jinan, Shandong province, the People’s Republic of China (“PRC”) and placed control over 6,912,503 (or 52.9%) of the Company’s outstanding ordinary shares for sale. The Company believes this public auction failed due to no bidders] [No. 387 Dongming Road Weifang Shandong People’s Republic of China, Postal Code: 261061 x ¨ Form 20-F ¨ ¨ ¨ ¨ Yes On August 27, 2013, Fuwei Films (Holdings) Co., Ltd. (the “Company”), issued a press release announcing that the Company has become aware that the first public auction by which the Company’s controlling shareholder, the Weifang State-owned Assets Operation]
JASO [JA Solar] 6-K: JA Solar to Develop 300 MW of Solar
[JA Solar to Develop 300 MW of Solar Power Projects in Xingtai City, Hebei Province SHANGHAI, China, August 27, 2013 JA Solar Holdings Co., Ltd. (Nasdaq:JASO) (JA Solar or the Company), one of the worlds largest manufacturers of high-performance solar power products, today announced that it plans to develop three solar power projects totaling 300 MW in Xingtai City]
LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)
[CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (the Company) (Stock Code: 2628) ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2013 CHAIRMANS STATEMENT In the first half of 2013, the global economic recovery experienced difficulties, and the economic development in China faced intricate] [Description 99.1 Announcement, dated August 28, 2013]
KUTV [Ku6 Media] 6-K: (Original Filing)
[Ku6 Media Reports Unaudited Financial Results for the Second Quarter of Fiscal Year 2013 BEIJING, China, August 28, 2013 Ku6 Media Co., Ltd. (Ku6 Media or the Company, NASDAQ: KUTV), a leading internet video company focused on User Generated Content (UGC) in China, today announced unaudited financial results for the second quarter of fiscal year 2013, ended June 30,]
